Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy.

× No keyword cloud information.

19 in total

Review 1. Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy.

Authors: Shigeru Kusumoto; Yasuhito Tanaka; Ryuzo Ueda; Masashi Mizokami
Journal: J Gastroenterol Date: 2010-10-06 Impact factor: 7.527

Review 2. Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

Authors: Harrys A Torres; Marta Davila
Journal: Nat Rev Clin Oncol Date: 2012-01-24 Impact factor: 66.675

3. The effect of rituximab on vaccine responses in patients with immune thrombocytopenia.

Authors: Ishac Nazi; John G Kelton; Mark Larché; Denis P Snider; Nancy M Heddle; Mark A Crowther; Richard J Cook; Alan T Tinmouth; Joy Mangel; Donald M Arnold
Journal: Blood Date: 2013-07-12 Impact factor: 22.113

4. Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors: a nationwide survey of medical oncologists.

Authors: Fiona L Day; Emma Link; Karin Thursky; Danny Rischin
Journal: J Oncol Pract Date: 2011-05 Impact factor: 3.840

Review 5. Management of chronic hepatitis B in patients from special populations.

Authors: Ching-Lung Lai; Man-Fung Yuen
Journal: Cold Spring Harb Perspect Med Date: 2015-06-01 Impact factor: 6.915

6. Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.

Authors: Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal: Hepatol Int Date: 2011-06-14 Impact factor: 6.047

7. Patients with hematological malignancies and serological signs of prior resolved hepatitis B.

Authors: Massimo Marignani; Elia Gigante; Paola Begini; Alfredo Marzano; Michela di Fonzo; Ilaria Deli; Sara Gallina; Maria Christina Cox; Gianfranco Delle Fave
Journal: World J Gastrointest Oncol Date: 2012-03-15

8. Detection of the Incidence of HBV, HCV Infection and Febrile Neutropenia Associated With CHOP With or Without Rituximab in Diffuse Large B-Cell Lymphoma-Treated Patients.

Authors: Kashif Ali; Ali Akbar Sial; Mirza Tasawer Baig; Nida Baig; Saqib Hussain Ansari; Tahir Sultan Shamsi
Journal: Hosp Pharm Date: 2017-11-16

9. Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis.

Authors: Zilin Tang; Xiaodong Li; Shunquan Wu; Yan Liu; Yan Qiao; Dongping Xu; Jin Li
Journal: Hepatol Int Date: 2017-08-30 Impact factor: 6.047

Review 10. Clinical impact of occult hepatitis B virus infection in immunosuppressed patients.

Authors: Evangelista Sagnelli; Mariantonietta Pisaturo; Salvatore Martini; Pietro Filippini; Caterina Sagnelli; Nicola Coppola
Journal: World J Hepatol Date: 2014-06-27